Sana Biotechnology Inc [SANA] stock is trading at $2.93, up 10.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SANA shares have gain 13.57% over the last week, with a monthly amount glided 3.17%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on March 14, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $7. Previously, TD Cowen upgraded its rating to Buy on January 08, 2025. On November 05, 2024, downgrade downgraded it’s rating to Mkt Perform. Rodman & Renshaw started tracking the stock assigning a Buy rating and suggested a price target of $16 on June 26, 2024. H.C. Wainwright upgraded its rating to a Buy but $12 remained the price target by the analyst firm on January 16, 2024. JMP Securities started tracking with a Mkt Outperform rating for this stock on September 25, 2023, and assigned it a price target of $9. In a note dated September 05, 2023, Citigroup initiated an Buy rating and provided a target price of $8 on this stock.
Sana Biotechnology Inc [SANA] stock has fluctuated between $1.52 and $10.50 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $2.93 at the most recent close of the market. An investor can expect a potential return of 173.04% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.94 and Total Capital is -0.58. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.72 points at the first support level, and at 2.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.04, and for the 2nd resistance point, it is at 3.15.
Ratios To Look Out For
For context, Sana Biotechnology Inc’s Current Ratio is 4.47. Further, the Quick Ratio stands at 4.47, while the Cash Ratio is 2.7.
Transactions by insiders
Recent insider trading involved CHRISTIAN HORDO & KATHARINE HO, Officer, that happened on Feb 18 ’25 when 75000.0 shares were purchased. Officer, CHRISTIAN HORDO & KATHARINE HO completed a deal on Jan 16 ’25 to buy 75000.0 shares. Meanwhile, See Remark 1 FMR LLC sold 0.29 million shares on Jan 08 ’25.
